Josef von Rickenbach, President & Chief Executive Officer, PAREXEL International Corporation

“The Boston Millennia team acted as a true business partner as we grew our company. They helped refine our business strategy and worked closely with us as we became a leader in the contract research and medical marketing industry. We are now the third largest Contract Research Organization in the world, with approximately 20,000 employees in 70 countries. Together, we have built a sustainable international organization. BMP was instrumental in designing our acquisition program and provided consulting services to us early on that refined our strategy. We have completed over 44 acquisitions to date with their support. Even today, twenty-five years after their initial investment, the BMP team continues to assist us as we execute our evolving growth strategy.”

Josef von Rickenbach
President & Chief Executive Officer PAREXEL International Corporation
Bob Shelman, President and Chief Executive Officer Odyssey Logistics

“As Odyssey has grown rapidly, fueled by strong multiyear organic performance and our strategic acquisition program, Boston Millennia Partners has been a trusted partner and supporter. They have provided valued advice and experience to us, and have been a steady presence as we mapped out the strategies that have led to our success. They have always had management’s best interests in mind, and I appreciate the actionable ideas they have provided us with regard to new acquisitions, hiring, and strategy.”

Bob Shelman
President and Chief Executive Officer Odyssey Logistics
Eugene Schneider, Chief Executive Officer, Director,  MedAptus, Inc.

“The BMP team has been a great partner for MedAptus, having helped our firm grow from an early-stage company to a meaningful and scalable organization today. They have supported our group by opening their network to potential customers, top executive talent, and business partners. Additionally, they provide us support from their Associate Team on a regular basis to help guide our strategic direction by sourcing acquisition candidates, providing market research, and operating as an external business development arm. They let us run our business without interfering in the operations but add to the strategic thinking on our focus and industry direction. We are very excited to work with BMP to continue leading the evolution of digital health with cutting edge information technology that services over 20,000 providers across 100+ top-tier healthcare networks.”

Eugene Schneider
Chief Executive Officer, Director MedAptus, Inc.
Adam Gridley, President and Chief Executive Officer Histogenics

“The team at BMP has been a long-time investor and supporter of our company. Dana, Rob & Marty are thoughtful, supportive and well connected within the biotechnology and medtech community – their expertise, and the benefits of both operator and investor perspectives have been invaluable as we’ve grown our company. They have been exceptional investors and partners for our organization and are truly vested in helping organizations develop products that meet unmet therapeutic needs.”

Adam Gridley
President and Chief Executive Officer Histogenics
Charles E. Hutchinson, Ph.D., Co-Founder, Chief Executive Officer, Director, GlycoFi, Inc.

“The BMP organization has been a strong supporter of Glycofi beyond funding our growth plan. They worked with us at key points in our evolution to assess the company’s strategic, product and services offerings, as well as analyzing when was an optimum time to partner the company with a major pharmaceutical company. They were instrumental in guiding us in the sale of the company to Merck that resulted in a 10x return for all.”

Charles E. Hutchinson
Ph.D., Co-Founder, Chief Executive Officer, Director GlycoFi, Inc.
Jane Hirsch, Collegium Pharmaceutical

“The Boston Millennia Partners team provided support and guidance when needed. Not only were they financially supportive but they asked good questions and helped Collegium to continue to progress. Their experience in the pharmaceutical industry was crucial in building our business and with their support we were able to work together to find a strategy that fit best for Collegium. With Boston Millennia Partners we were able to find an investor that truly became a strong partner as well.”

Jane Hirsch
Co-Founder Collegium Pharmaceutical
Richard Love, President & Chief Executive Officer, ILEX Oncology, Inc.

“Boston Millennia’s professionals added tangible value to ILEX from day one because they could draw upon their extensive experience in the outsourced pharmaceutical services industry. As an active Board member, Dana helped us expand our management team, refine our strategy, and reorganize our business to provide better service for our pharmaceutical clients. We gained a better understanding of the service side of our business as a result which reduced risk for all of our constituents.”

Richard Love
President & Chief Executive Officer ILEX Oncology, Inc.
Mike Koziel , CEO, President & Founder , Athenix

“While the founders of Athenix have brought several products to market as part of larger organizations Athenix is our first experience building a venture backed company. We needed more than capital. Boston Millennia has been particularly helpful to Athenix by making available specific firm expertise and insight in commercialization strategy. BMP has been instrumental in all phases of our growth from start-up to the recent negotiation of our first multi-year, multi-million dollar product development partnership. Boston Millennia brings valuable judgment and insight in business development, finance, fundraising, and strategy. We are very pleased to have such an active and committed investor.”

Mike Koziel
CEO, President & Founder Athenix